Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Methods Leveraging the target trial emulation framework, we conducted a retrospective study using observational data to emulate a new user, active comparator trial examining the effects of initiating GLP-1RA (exposure group) versus SGLT2 inhibitors (control group), with random treatment assignment emulated by propensity score matching with 1:1 ratio
:max_bytes(150000):strip_icc()/VWH-GettyImages-1692436619-6afbd0305e5e42359effc8b3deda6818.jpg)
The question is which one fits a specific metabolic situation
When weight loss flattened out around week 40-44, participants did not start regaining
Kailera IPO'd in 2025 with HRS9531 (dual GLP-1/GIP, Phase 3 China readout ~17.7% weight loss February 2026) as its lead asset and HRS-4729 (the triple agonist) as an earlier-stage follow-on
Isotretinoin (generic for Accutane) treats severe nodular acne that is unresponsive to other treatments
This ingredient has some brightening potential but it's more of a prevention ingredient than spot-fader
US$ 23.34
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 24.20
US$ 22.88
US$ 21.52
